Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data

Observational studies are often considered unreliable for evaluating relative treatment effectiveness, but it has been suggested that following target trial protocols could reduce bias. Using observational data from patients with rheumatoid arthritis (RA) in the Swedish Rheumatology Quality Register...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbulescu, Andrei, Askling, Johan, Saevarsdottir, Saedis, Kim, Seoyoung C., Frisell, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540175/
https://www.ncbi.nlm.nih.gov/pubmed/35652244
http://dx.doi.org/10.1002/cpt.2673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540175/
https://www.ncbi.nlm.nih.gov/pubmed/35652244
http://dx.doi.org/10.1002/cpt.2673

Ejemplares similares